EP Patent

EP3659604A1 — Methods of providing weight loss therapy in patients with major depression

Assigned to Nalpropion Pharmaceuticals LLC · Expires 2020-06-03 · 6y expired

What this patent protects

Disclosed are methods of providing weight loss therapy, particularly for patients suffering from major depression.

USPTO Abstract

Disclosed are methods of providing weight loss therapy, particularly for patients suffering from major depression.

Drugs covered by this patent

Patent Metadata

Patent number: EP3659604A1
Jurisdiction: EP
Classification: —
Expires: 2020-06-03
Drug substance claim: No
Drug product claim: No
Assignee: Nalpropion Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.